Motus GI Holdings

General Information

We have developed a single-use medical device system (the “Pure-Vu system”), cleared by the United States Food and Drug Administration (the “FDA”), that is intended to connect to standard colonoscopes to help facilitate intraprocedural cleaning of a poorly prepared colon by irrigating or cleaning the colon and evacuating the irrigation fluid (water), feces and other bodily fluids and matter. The Pure-Vu system has been designed to integrate with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. Our Pure-Vu system and the procedure to cleanse the colon in preparation for colonoscopy are not currently reimbursable through private or governmental third-party payors in any country, but we intend to seek reimbursement through private or governmental third-party payors in the future.

Employees: 36
Founded: 2016
Contact Information
Address Keren Hayesod 22, Tirat Carmel, Israel, 3902638
Phone Number 786 459 1831
Web Address
View Prospectus: Motus GI Holdings
Financial Information
Market Cap $77.9mil
Revenues $0 mil (last 12 months)
Net Income $-7.4 mil (last 12 months)
IPO Profile
Symbol MOTS
Exchange NASDAQ
Shares (millions): 3.5
Price range $5.00 - $5.00
Est. $ Volume $17.5 mil
Manager / Joint Managers Piper Jaffray
CO-Managers Oppenheimer & Co.
Expected To Trade: 2/14/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change